Literature DB >> 2009371

Two distinct loci on the short arm of chromosome 16 are involved in myeloid leukemia.

J W Wessels1, P Mollevanger, J G Dauwerse, F H Cluitmans, M H Breuning, G C Beverstock.   

Abstract

We report a case of acute nonlymphocytic leukemia (ANLL) M5 with the characteristic t(8;16)(p11;p13). The breakpoint in the short arm was regionally localized using nonradioactive in situ hybridization with a series of cosmids of chromosome 16. The results show that a difference exists between the breakpoint in chromosome 16(p13) in this t(8;16) and the breakpoint involved in the short arm in the characteristic inversion 16 (p13;q22)) that occurs in ANLL M4eo. Two different loci appear to be involved in these chromosomal rearrangements.

Entities:  

Mesh:

Year:  1991        PMID: 2009371

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.

Authors:  M Oelgeschläger; R Janknecht; J Krieg; S Schreek; B Lüscher
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.

Authors:  V Facchinetti; L Loffarelli; S Schreek; M Oelgeschläger; B Lüscher; M Introna; J Golay
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

3.  Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3.

Authors:  M H Breuning; H G Dauwerse; G Fugazza; J J Saris; L Spruit; H Wijnen; N Tommerup; C B van der Hagen; K Imaizumi; Y Kuroki; M J van den Boogaard; J M de Pater; E C Mariman; B C Hamel; H Himmelbauer; A M Frischauf; R Stallings; G C Beverstock; G J van Ommen; R C Hennekam
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

4.  A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

Authors:  Y Laâbi; M P Gras; F Carbonnel; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.